Prostaglandin E2 levels of aqueous and vitreous humor in ketorolac 0.4% and nepafenac 0.1% administered healthy rabbits
Göster/ Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2017Yazar
Acar, UğurErgintürk Acar, Damla
Tanrıverdi, Cafer
Acar, Mutlu
Özdemir, Özdemir
Erikci, Açelya
Örnek, Firdevs
Üst veri
Tüm öğe kaydını gösterKünye
Acar, U., Ergintürk Acar, D., Tanrıverdi, C., Acar, M., Özdemir, Ö., Erikçi, A. ... Örnek, F. (2017). Prostaglandin E2 levels of aqueous and vitreous humor in ketorolac 0.4% and nepafenac 0.1% administered healthy rabbits. Ocular Immunology and Inflammation, 25(3), 323-327. https://dx.doi.org/10.3109/09273948.2015.1116587Özet
Purpose: To compare the lowering effects of ketorolac 0.4% and nepafenac 0.1% on aqueous and vitreous humor prostaglandin E-2 (PGE(2)) levels in rabbits.Methods: Ketorolac and nepafenac ophthalmic solutions were administered to the right eyes of 24 healthy rabbits after randomized division into two groups. The left eyes of these rabbits were considered as controls for the two groups. On the 4th day of the experiment, the samples were taken from the aqueous and vitreous humors of the rabbits bilaterally, and PGE(2) levels were measured by an enzyme immune assay kit.Results: Ketorolac and nepafenac achieved a statistically significant decrease (p<0.001, for each) in PGE(2) levels in the aqueous (11.75 6.15 and 14.75 +/- 7.60 pg/mL, respectively) and the vitreous humor (6.58 +/- 4.62 and 9.83 +/- 4.55 pg/mL, respectively).Conclusions: Both ketorolac and nepafenac inhibited PGE(2) levels in both the aqueous and vitreous humors of rabbits. Although PGE(2)-lowering effects were similar in the aqueous humor, nepafenac seemed to be more potent than ketorolac in the vitreous humor.
Scopus Q Kategorisi
Q2Kaynak
Ocular Immunology and InflammationCilt
25Sayı
3Koleksiyonlar
- Makale Koleksiyonu [3651]
- PubMed İndeksli Yayınlar Koleksiyonu [4049]
- Scopus İndeksli Yayınlar Koleksiyonu [6285]
- WoS İndeksli Yayınlar Koleksiyonu [6432]